OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Proteomics
(1)
Organisms
Mus musculus
(1)
Repository
pride
(1)
Tissue
Cardiocyte
(1)
Heart
(1)
Disease
Cardiovascular system disease
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2017
(1)
Release Date
2023
(2)
2025
(1)
2022
(1)
Lab affiliation
Master program for clinical pharmacogehomics and pharmacoprotemics Chia-Li Han LAB.Taipei
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Mouse cardiomyocytes LC/MS/MS - Membrane Proteomics of Impaired Energetics and Cytoskeletal Disorganization in Elderly Diet-Induced Diabetic Mice
Differential Membrane Proteomics Profiles of isolated cardio myocytes in HFD mice
ORGANISM(S):
Mus musculus (Mouse)
2017-08-28
|
PXD002881
|
Pride
Hp-rp stagetip fractionation
Lc/ms/ms
Mouse cardiomyocytes
Itraq labeling
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
